Cathepsin B, L, and S cleave and inactivate secretory leucoprotease inhibitor - PubMed (original) (raw)
. 2001 Sep 7;276(36):33345-52.
doi: 10.1074/jbc.M103220200. Epub 2001 Jul 2.
Affiliations
- PMID: 11435427
- DOI: 10.1074/jbc.M103220200
Free article
Cathepsin B, L, and S cleave and inactivate secretory leucoprotease inhibitor
C C Taggart et al. J Biol Chem. 2001.
Free article
Abstract
A number of serine proteases, matrix metalloproteases, and cysteine proteases were evaluated for their ability to cleave and inactivate the antiprotease, secretory leucoprotease inhibitor (SLPI). None of the serine proteases or the matrix metalloproteases examined cleaved the SLPI protein. However, incubation with cathepsins B, L, and S resulted in the cleavage and inactivation of SLPI. All three cathepsins initially cleaved SLPI between residues Thr(67) and Tyr(68). The proteolytic cleavage of SLPI by all three cathepsins resulted in the loss of the active site of SLPI and the inactivation of SLPI anti-neutrophil elastase capacity. Cleavage and inactivation were catalytic with respect to the cathepsins, so that the majority of a 400-fold excess of SLPI was inactivated within 15 min by cathepsins L and S. Analysis of epithelial lining fluid samples from individuals with emphysema indicated the presence of cleaved SLPI in these samples whereas only intact SLPI was observed in control epithelial lining fluid samples. Active cathepsin L was shown to be present in emphysema epithelial lining fluid and inhibition of this protease prevented the cleavage of recombinant SLPI added to emphysema epithelial lining fluid. Taken together with previous data that demonstrates that cathepsin L inactivates alpha(1)-antitrypsin, these findings indicate the involvement of cathepsins in the diminution of the lung antiprotease screen possibly leading to lung destruction in emphysema.
Similar articles
- Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor.
Vogelmeier C, Hubbard RC, Fells GA, Schnebli HP, Thompson RC, Fritz H, Crystal RG. Vogelmeier C, et al. J Clin Invest. 1991 Feb;87(2):482-8. doi: 10.1172/JCI115021. J Clin Invest. 1991. PMID: 1671391 Free PMC article. - Identification, origins and the diurnal role of the principal serine protease inhibitors in human tear fluid.
Sathe S, Sakata M, Beaton AR, Sack RA. Sathe S, et al. Curr Eye Res. 1998 Apr;17(4):348-62. doi: 10.1080/02713689808951215. Curr Eye Res. 1998. PMID: 9561826 - Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation.
Weldon S, McNally P, McElvaney NG, Elborn JS, McAuley DF, Wartelle J, Belaaouaj A, Levine RL, Taggart CC. Weldon S, et al. J Immunol. 2009 Dec 15;183(12):8148-56. doi: 10.4049/jimmunol.0901716. J Immunol. 2009. PMID: 20007580 Free PMC article. - Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.
Abboud RT, Vimalanathan S. Abboud RT, et al. Int J Tuberc Lung Dis. 2008 Apr;12(4):361-7. Int J Tuberc Lung Dis. 2008. PMID: 18371259 Review. - Cysteine Cathepsins in the secretory vesicle produce active peptides: Cathepsin L generates peptide neurotransmitters and cathepsin B produces beta-amyloid of Alzheimer's disease.
Hook V, Funkelstein L, Wegrzyn J, Bark S, Kindy M, Hook G. Hook V, et al. Biochim Biophys Acta. 2012 Jan;1824(1):89-104. doi: 10.1016/j.bbapap.2011.08.015. Epub 2011 Sep 8. Biochim Biophys Acta. 2012. PMID: 21925292 Free PMC article. Review.
Cited by
- Versatile whey acidic protein four-disulfide core domain proteins: biology and role in diseases.
Wen Y, Jiang N, Wang Z, Xiao Y. Wen Y, et al. Front Cell Dev Biol. 2024 Sep 4;12:1459129. doi: 10.3389/fcell.2024.1459129. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39296934 Free PMC article. Review. - Neutrophil-Derived Proteases in Lung Inflammation: Old Players and New Prospects.
Cheetham CJ, McKelvey MC, McAuley DF, Taggart CC. Cheetham CJ, et al. Int J Mol Sci. 2024 May 17;25(10):5492. doi: 10.3390/ijms25105492. Int J Mol Sci. 2024. PMID: 38791530 Free PMC article. Review. - The secretory leukocyte protease inhibitor (SLPI) in pathophysiology of non-communicable diseases: Evidence from experimental studies to clinical applications.
Mongkolpathumrat P, Pikwong F, Phutiyothin C, Srisopar O, Chouyratchakarn W, Unnajak S, Nernpermpisooth N, Kumphune S. Mongkolpathumrat P, et al. Heliyon. 2024 Jan 17;10(2):e24550. doi: 10.1016/j.heliyon.2024.e24550. eCollection 2024 Jan 30. Heliyon. 2024. PMID: 38312697 Free PMC article. Review. - Gelatin-coated silicon oxide nanoparticles encapsulated recombinant human secretory leukocyte protease inhibitor (rhSLPI) reduced cardiac cell death against an in vitro simulated ischaemia/reperfusion injury.
Pikwong F, Phutiyothin C, Chouyratchakarn W, Baipaywad P, Mongkolpathumrat P, Kumphune S. Pikwong F, et al. Heliyon. 2023 Sep 16;9(9):e20150. doi: 10.1016/j.heliyon.2023.e20150. eCollection 2023 Sep. Heliyon. 2023. PMID: 37809945 Free PMC article. - Airway microbiome-immune crosstalk in chronic obstructive pulmonary disease.
Kayongo A, Robertson NM, Siddharthan T, Ntayi ML, Ndawula JC, Sande OJ, Bagaya BS, Kirenga B, Mayanja-Kizza H, Joloba ML, Forslund SK. Kayongo A, et al. Front Immunol. 2023 Jan 17;13:1085551. doi: 10.3389/fimmu.2022.1085551. eCollection 2022. Front Immunol. 2023. PMID: 36741369 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources